Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results

Michael Larsen, Ursula Schmidt-Erfurth, Paolo Lanzetta, Sebastian Wolf, Christian Simader, Erika Tokaji, Stefan Pilz, Annemarie Weisberger, MONT BLANC Study Group

    93 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results'. Together they form a unique fingerprint.

    Medicine & Life Sciences